Search

Your search keyword '"Rogers, Toby"' showing total 342 results
Start Over Author "Rogers, Toby" Search Limiters Peer Reviewed Publication Year Range Last 3 years Publication Type Academic Journals

Refine your results

more »

more »

more »

more »
342 results on '"Rogers, Toby"'

4. Transcatheter Mitral Cerclage Ventriculoplasty From Bench to Bedside

Author

Rogers, Toby, Greenbaum, Adam B, Babaliaros, Vasilis C, Foerst, Jason R, Khan, Jaffar M, Bruce, Christopher G, Stine, Annette M, Satler, Lowell F, Perdoncin, Emily, Gleason, Patrick T, Lisko, John C, Tian, Xin, Miao, Rui, Sachdev, Vandana, Chen, Marcus Y, and Lederman, Robert J

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Sciences, Heart Disease, Clinical Research, Cardiovascular, Biomedical Imaging, Heart Disease - Coronary Heart Disease, Cardiac Catheterization, Heart Failure, Heart Valve Prosthesis Implantation, Humans, Mitral Valve, Mitral Valve Insufficiency, Prospective Studies, Treatment Outcome, Ventricular Dysfunction, Left, cardiomyopathy, heart failure, secondary mitral regurgitation, transcatheter annuloplasty, transcatheter ventriculoplasty, ventricular repair, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology
Abstract

BackgroundTranscatheter mitral valve repair is beneficial in patients with mitral regurgitation (MR), left ventricular dysfunction, and persistent symptoms despite maximally tolerated medical therapy.ObjectivesThe aim of this study was to evaluate the safety and feasibility of transcatheter mitral cerclage ventriculoplasty in patients with MR and either heart failure with reduced ejection fraction or preserved ejection fraction and in subjects with prior edge-to-edge repair but persistent or recurrent symptomatic MR.MethodsThe National Heart, Lung, and Blood Institute Division of Intramural Research Transcatheter Mitral Cerclage Ventriculoplasty Early Feasibility Study (NCT03929913) was an investigator-initiated prospective multicenter study. The primary endpoint was technical success measured at exit from the catheterization laboratory. Follow-up included heart failure quality-of-life assessments and serial imaging with echocardiography and cardiac computed tomography.ResultsNineteen subjects consented and underwent cerclage, 63% with heart failure with reduced ejection fraction and 37% with heart failure with preserved ejection fraction, with ischemic cardiomyopathy in 26% and nonischemic cardiomyopathy in 74%. There were no procedural deaths, strokes, or transient ischemic attacks or other major cardiovascular adverse events. The primary endpoint was met in 17 subjects. Cerclage induced sustained reductions in mitral regurgitant volume (-41%) and effective orifice area (-33%) after a median of 337 days. Cerclage resulted in improvements in 6-minute walking distance (+78 m) and Kansas City Cardiomyopathy Questionnaire Overall Summary Score (+22 points) at 30 days that were maintained after a median of 265 days. New complete heart block developed in 6 of 17 subjects. Three deaths occurred on postprocedural days 79, 159, and 756, unrelated to cerclage.ConclusionsTranscatheter mitral cerclage ventriculoplasty resulted in significant and sustained improvements in mitral regurgitation and in heart failure quality-of-life assessments.

Published
2022

6. Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction

Author

Greenbaum, Adam B., Ueyama, Hiroki A., Gleason, Patrick T., Khan, Jaffar M., Bruce, Christopher G., Halaby, Rim N., Rogers, Toby, Hanzel, George S., Xie, Joe X., Byku, Isida, Guyton, Robert A., Grubb, Kendra J., Lisko, John C., Shekiladze, Nikoloz, Inci, Errol K., Grier, Elizabeth A., Paone, Gaetano, McCabe, James M., Lederman, Robert J., and Babaliaros, Vasilis C.

Published
2024
Full Text
View/download PDF

8. Autism Tsunami: The Impact of Rising Prevalence on the Societal Cost of Autism in the United States

Author

Blaxill, Mark, Rogers, Toby, and Nevison, Cynthia

Abstract

The cost of ASD in the U.S. is estimated using a forecast model that for the first time accounts for the true historical increase in ASD. Model inputs include ASD prevalence, census population projections, six cost categories, ten age brackets, inflation projections, and three future prevalence scenarios. Future ASD costs increase dramatically: total base-case costs of $223 (175-271) billion/year are estimated in 2020; $589 billion/year in 2030, $1.36 trillion/year in 2040, and $5.54 (4.29-6.78) trillion/year by 2060, with substantial potential savings through ASD prevention. Rising prevalence, the shift from child to adult-dominated costs, the transfer of costs from parents onto government, and the soaring total costs raise pressing policy questions and demand an urgent focus on prevention strategies.

Published
2022
Full Text
View/download PDF

9. Self-expanding and balloon-expandable valves in low risk TAVR patients

Author

Bhogal, Sukhdeep, Waksman, Ron, Shea, Corey, Zhang, Cheng, Gordon, Paul, Ehsan, Afshin, Wilson, Sean R., Levitt, Robert, Parikh, Puja, Bilfinger, Thomas, Hanna, Nicholas, Buchbinder, Maurice, Asch, Federico M., Weissman, Gaby, Ben-Dor, Itsik, Shults, Christian C., Ali, Syed, Garcia-Garcia, Hector M., Satler, Lowell F., and Rogers, Toby

Published
2024
Full Text
View/download PDF

10. High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?

Author

Chitturi, Kalyan R., Zhang, Cheng, Abusnina, Waiel, Sawant, Vaishnavi, Banerjee, Avantika, Ahmed, Shaan, Merdler, Ilan, Haberman, Dan, Chaturvedi, Abhishek, Lupu, Lior, Reddy, Pavan, Case, Brian C., Rogers, Toby, Hashim, Hayder D., Ben-Dor, Itsik, Bernardo, Nelson L., Satler, Lowell F., and Waksman, Ron

Published
2024
Full Text
View/download PDF

14. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Author

Tang, Gilbert H.L., Spencer, Julianne, Rogers, Toby, Grubb, Kendra J., Gleason, Patrick, Gada, Hemal, Mahoney, Paul, Dauerman, Harold L., Forrest, John K., Reardon, Michael J., Blanke, Philipp, Leipsic, Jonathon A., Abdel-Wahab, Mohamed, Attizzani, Guilherme F., Puri, Rishi, Caskey, Michael, Chung, Christine J., Chen, Ying-Hwa, Dudek, Dariusz, Allen, Keith B., Chhatriwalla, Adnan K., Htun, Wah Wah, Blackman, Daniel J., Tarantini, Giuseppe, Zhingre Sanchez, Jorge, Schwartz, Greta, Popma, Jeffrey J., and Sathananthan, Janarthanan

Published
2023
Full Text
View/download PDF

19. A systematic conservation plan identifying critical areas for improved chondrichthyan protection in South Africa

Author

Faure-Beaulieu, Nina, Lombard, Amanda T., Olbers, Jennifer, Goodall, Victoria, da Silva, Charlene, Daly, Ryan, Jordaan, Gareth, Kerwath, Sven E., Kock, Alison, Mann, Bruce Q., Murray, Taryn S., Albano, Patricia, Cliff, Geremy, dos Santos, Natalie A., Gennari, Enrico, Hammerschlag, Neil, Bester-van der Merwe, Aletta E., Watson, Ralph, Andreotti, Sara, Bernard, Anthony T.F., Cowley, Paul D., De Vos, Lauren, Drobniewska, Natalia, Elston, Chantel, Fallows, Chris, Rogers, Toby D., Smith, Grant, van Staden, Michaela, de Villiers, Pierre, Paulet, Timothy Guy, and Harris, Jean

Published
2023
Full Text
View/download PDF

22. TAVR in 2023: Who Should Not Get It?

Author

Bhogal, Sukhdeep, Rogers, Toby, Aladin, Amer, Ben-Dor, Itsik, Cohen, Jeffrey E., Shults, Christian C., Wermers, Jason P., Weissman, Gaby, Satler, Lowell F., Reardon, Michael J., Yakubov, Steven J., and Waksman, Ron

Published
2023
Full Text
View/download PDF

24. Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction Model

Author

Khan, Jaffar M., Kamioka, Norihiko, Lisko, John C., Perdoncin, Emily, Zhang, Cheng, Maini, Aneel, Chen, Mao, Li, Yijian, Ludwig, Sebastian, Westermann, Dirk, Amat Santos, Ignacio J., Kalińczuk, Łukasz, Sinning, Jan-Malte, Kawaguchi, Tomohiro, Fuku, Yasushi, Cheema, Asim N., Félix-Oliveira, Afonso, Yamamoto, Masanori, Kagase, Ai, Codner, Pablo, Valle, Raquel del, Iyer, Vijay S., Kim, Hyo-Soo, Lin, Mao-Shin, Maini, Brijeshwar, Rodriguez, Roberto, Montorfano, Matteo, Ancona, Marco B., Tada, Norio, Miyasaka, Masaki, Ahmad, Hasan, Ruggiero, Nicholas J., Torguson, Rebecca, Ben-Dor, Itsik, Shults, Christian C., Weissman, Gaby, Lederman, Robert J., Greenbaum, Adam B., Babaliaros, Vasilis C., Waksman, Ron, and Rogers, Toby

Published
2023
Full Text
View/download PDF

26. RETRACTED ARTICLE: Autism Tsunami: the Impact of Rising Prevalence on the Societal Cost of Autism in the United States

Author

Blaxill, Mark, Rogers, Toby, and Nevison, Cynthia

Subjects
Medical care, Cost of -- Evaluation, Pervasive developmental disorders -- Diagnosis -- Distribution, Company distribution practices, Health
Abstract

The cost of ASD in the U.S. is estimated using a forecast model that for the first time accounts for the true historical increase in ASD. Model inputs include ASD prevalence, census population projections, six cost categories, ten age brackets, inflation projections, and three future prevalence scenarios. Future ASD costs increase dramatically: total base-case costs of $223 (175-271) billion/year are estimated in 2020; $589 billion/year in 2030, $1.36 trillion/year in 2040, and $5.54 (4.29-6.78) trillion/year by 2060, with substantial potential savings through ASD prevention. Rising prevalence, the shift from child to adult-dominated costs, the transfer of costs from parents onto government, and the soaring total costs raise pressing policy questions and demand an urgent focus on prevention strategies., Author(s): Mark Blaxill [sup.1] , Toby Rogers [sup.2] , Cynthia Nevison [sup.3] Author Affiliations: (1) Holland Center, , Minnetonka, MN, USA (2) Pasadena, CA, USA (3) grid.266190.a, 0000000096214564, Institute for [...]

Published
2022
Full Text
View/download PDF

28. Reshaping the Ventricle From Within: MIRTH (Myocardial Intramural Remodeling by Transvenous Tether) Ventriculoplasty in Swine

Author

Bruce, Christopher G., Khan, Jaffar M., Rogers, Toby, Yildirim, D. Korel, Jaimes, Andrea E., Seemann, Felicia, Chen, Marcus Y., O’Brien, Kendall, Herzka, Daniel A., Schenke, William H., Eckhaus, Michael A., Potersnak, Amanda G., Campbell-Washburn, Adrienne, Babaliaros, Vasilis C., Greenbaum, Adam B., and Lederman, Robert J.

Published
2023
Full Text
View/download PDF

30. Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes

Author

Waksman, Ron, Bhogal, Sukhdeep, Gordon, Paul, Ehsan, Afshin, Wilson, Sean R., Levitt, Robert, Parikh, Puja, Bilfinger, Thomas, Hanna, Nicholas, Buchbinder, Maurice, Asch, Federico M., Kim, Francis Y., Weissman, Gaby, Ben-Dor, Itsik, Shults, Christian C., Ali, Syed, Sutton, Joseph A., Shea, Corey, Zhang, Cheng, Garcia-Garcia, Hector M., Satler, Lowell F., and Rogers, Toby

Published
2023
Full Text
View/download PDF

31. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review

Author

Pibarot, Philippe, Herrmann, Howard C., Wu, Changfu, Hahn, Rebecca T., Otto, Catherine M., Abbas, Amr E., Chambers, John, Dweck, Marc R., Leipsic, Jonathon A., Simonato, Matheus, Rogers, Toby, Sathananthan, Janarthanan, Guerrero, Mayra, Ternacle, Julien, Wijeysundera, Harindra C., Sondergaard, Lars, Barbanti, Marco, Salaun, Erwan, Généreux, Philippe, Kaneko, Tsuyoshi, Landes, Uri, Wood, David A., Deeb, G. Michael, Sellers, Stephanie L., Lewis, John, Madhavan, Mahesh, Gillam, Linda, Reardon, Michael, Bleiziffer, Sabine, O’Gara, Patrick T., Rodés-Cabau, Josep, Grayburn, Paul A., Lancellotti, Patrizio, Thourani, Vinod H., Bax, Jeroen J., Mack, Michael J., and Leon, Martin B.

Published
2022
Full Text
View/download PDF

35. A Guide to Transcatheter Aortic Valve Design and Systematic Planning for a Redo-TAV (TAV-in-TAV) Procedure.

Author

Bapat, Vinayak N., Fukui, Miho, Zaid, Syed, Okada, Atsushi, Jilaihawi, Hasan, Rogers, Toby, Khalique, Omar, Cavalcante, João L., Landes, Uri, Sathananthan, Janarthanan, Tarantini, Giuseppe, Tang, Gilbert H.L., Blackman, Daniel J., De Backer, Ole, Mack, Michael J., and Leon, Martin B.

Abstract

Transcatheter aortic valve replacement (TAVR) has become more common than surgical aortic valve replacement since 2016, with over 200,000 procedures globally each year. As patients increasingly outlive their TAVR devices, managing these cases is a growing concern. Treatment options include surgical removal of the old TAVR device (transcatheter aortic valve [TAV] explant) or implantation of a new transcatheter aortic valve (redo TAV). Redo TAV is complex because of the unique designs of TAV devices; compatibility issues; and the need for individualized planning based on factors such as implant depth, shape, and coronary artery relationships. This review serves as a comprehensive guide for redo TAV, detailing the design characteristics of TAV devices, device compatibility, standardized terminology, and a structured approach for computed tomography analysis. It aims to facilitate decision making, risk identification, and achieving optimal outcomes in redo TAV procedures. [Display omitted] • Because TAVR has now expanded to patients with longer life expectancies, increasing numbers of patients will present with structural valve deterioration of TAV prostheses. It is important to understand the risks and suitability of patients for repeat implantation of another TAV (redo TAV or TAV-in-TAV). • Unlike valve-in-valve for failed surgical aortic valve replacement because of the complexity of TAV designs, a systematic CT analysis for each combination is necessary to determine suitability with respect to coronary risk, sizing, and injury to the surrounding structures. • Bench testing, prospective clinical studies, and validation of CT algorithms with simulation software will play a critical role in appropriate case selection and improving outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

47. One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery

Author

Chezar-Azerrad, Chava, Musallam, Anees, Shea, Corey, Zhang, Cheng, Torguson, Rebecca, Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Khalid, Nauman, Khan, Jaffar M., Shlofmitz, Evan, Chen, Yuefeng, Satler, Lowell F., Bernardo, Nelson L., Ben-Dor, Itsik, Rogers, Toby, Hashim, Hayder, Mintz, Gary S., and Waksman, Ron

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results